2015 Biosimilars Chemotherapy 
Pharmacy Times
JUNE 12, 2025
The session, which was entitled “Decoding the Logic: An Overview of Biologics and Biosimilars,” described clinical applications and economic impacts associated with biologics and biosimilars over the last 10 to 15 years, as well as outlined what skills effectively contribute to their management and understanding.
pharmaphorum
JULY 18, 2025
Skip to main content Friday 18 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 19, 2021
Innovent has only released top-line data from the 480-subject ORIENT-31 study so far, but said sintilimab given with its bevacizumab biosimilar Byvasda on top of chemotherapy with Lilly’s own Alimta (pemetrexed) and cisplatin had a statistically significant improvement in PFS.
pharmaphorum
SEPTEMBER 8, 2020
billion in 2015. In my role at Sandoz, I work with teams that are passionately trying to drive healthcare sustainability through the increased use of high-quality biosimilars. Beyond significant cost savings, biosimilar uptake has been shown to simultaneously improve patient access, varying by country. In fact, an estimated 21.2
pharmaphorum
JULY 1, 2025
billion, Amgen has promising phase 3 results with a drug for gastric cancer that was the focal point for the deal. billion, Amgen has promising phase 3 results with a drug for gastric cancer that was the focal point for the deal. billion, Amgen has promising phase 3 results with a drug for gastric cancer that was the focal point for the deal.
PharmaShots
MARCH 29, 2023
Some companies accept the offered period and open doors to biological drugs or biosimilars. It is the only drug in its class of chemotherapy and is developed from the natural substance found in a sea sponge. As of now, there are no the US FDA approved biosimilars available for Actemra.
Pharmaceutical Technology
JULY 23, 2008
Analysts predict Pfizer’s revenue stream would be slashed by 25% by 2015 if the company did not branch out into other areas. “Companies used to be universally protected by patents but there is a pathway to approval opening up for biosimilar legislation. .
Expert insights. Personalized for you.
29 
Let's personalize your content